EXPO · XBRL financial data

Exponent financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (EXPO's year ends in early January)

In thousands of dollars	FY 2020Jan 1, 2021	FY 2021Dec 31, 2021	FY 2022Dec 30, 2022	FY 2023Dec 29, 2023	FY 2024Jan 3, 2025	FY 2025Jan 2, 2026
Revenue	399,900	466,269	513,293	536,766	558,514	582,014
Revenue from contracts with customers	399,900	466,269	513,293	536,766	558,514	582,014
General and administrative	12,888	15,282	23,660	24,440	22,726	25,521
Total operating expenses	316,651	357,342	372,451	425,444	438,957	462,227
Operating income (loss)	83,249	108,927	140,842	111,322	119,557	119,787
Other income (expense)	11,982	16,844	(10,704)	17,424	17,812	18,203
Income tax expense (benefit)	14,384	24,635	29,904	35,557	38,368	41,288
Net income (loss)	82,552	101,202	102,330	100,339	109,002	106,009
Earnings per share, basic USD per share	1.58	1.92	1.98	1.96	2.13	2.08
Earnings per share, diluted USD per share	1.55	1.90	1.96	1.94	2.11	2.07
Weighted average shares, basic thousands of shares	52,388	52,610	51,727	51,152	51,129	50,904
Weighted average shares, diluted thousands of shares	53,323	53,331	52,280	51,635	51,569	51,244

Fiscal years (EXPO's year ends in early January)

In thousands of dollars	FY 2020Jan 1, 2021	FY 2021Dec 31, 2021	FY 2022Dec 30, 2022	FY 2023Dec 29, 2023	FY 2024Jan 3, 2025	FY 2025Jan 2, 2026
Cash and cash equivalents	197,525	297,687	161,458	187,150	258,901	221,930
Short-term investments	45,001	—	—	—	—	—
Accounts receivable	111,565	139,861	170,114	167,360	161,407	181,507
Prepaid and other current assets	12,741	15,214	17,585	25,022	26,573	24,143
Total current assets	366,832	452,762	349,157	379,532	446,881	427,580
Property and equipment, net	59,823	59,971	65,539	75,318	73,007	71,981
Right-of-use asset	19,322	14,370	18,007	24,600	75,248	73,376
Goodwill	8,607	8,607	8,607	8,607	8,607	8,607
Total assets	580,096	683,739	586,662	646,777	777,270	777,519
Accounts payable	3,279	3,193	8,642	4,489	5,272	6,874
Accrued liabilities	13,048	21,311	20,473	17,636	16,864	24,068
Total current liabilities	117,308	152,982	159,029	161,909	163,183	178,002
Lease liability, non-current	14,343	9,807	13,343	21,959	76,084	75,944
Total liabilities	218,598	266,674	265,910	290,692	356,202	387,178
Retained earnings	421,809	478,370	528,810	574,082	624,151	668,423
Total stockholders' equity	361,498	417,065	320,752	356,085	421,068	390,341
Total liabilities and equity	580,096	683,739	586,662	646,777	777,270	777,519
Common shares outstanding (cover page) thousands of shares	51,804	52,116	50,642	50,563	50,818	49,254

Fiscal years (EXPO's year ends in early January)

In thousands of dollars	FY 2020Jan 1, 2021	FY 2021Dec 31, 2021	FY 2022Dec 30, 2022	FY 2023Dec 29, 2023	FY 2024Jan 3, 2025	FY 2025Jan 2, 2026
Net income (loss)	82,552	101,202	102,330	100,339	109,002	106,009
Stock-based compensation	17,278	19,263	20,364	20,357	23,239	23,795
Net cash from operating activities	103,312	124,568	93,807	127,352	144,537	131,730
Purchases of property and equipment	4,987	6,826	12,043	16,356	6,939	9,390
Net cash from investing activities	5,024	38,178	(12,043)	(16,356)	(6,939)	(9,390)
Share repurchases	40,049	7,000	155,856	24,208	5,710	97,095
Dividends paid	39,775	43,198	49,237	54,043	58,214	61,539
Net cash from financing activities	(88,355)	(62,753)	(215,977)	(86,009)	(65,108)	(160,428)
Net change in cash	21,089	100,162	(136,229)	25,692	71,751	(36,971)

SIC 8742 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8742 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Exponent	66,629	171,612	30,889*	47.5M	—	Q2 FY26 10-QJul 3, 2026
Huron Consulting Group	25,618	491,451	57,031*	15.8M	—	Q3 FY26 10-QSep 30, 2026
Fti Consulting	88,097	1,012,563	190,408*	27.3M	—	Q3 FY26 10-QSep 30, 2026
Premier	43,380	240,004	15,858	82.7M	—	Q1 FY26 10-QSep 30, 2025
ICF International	4,618	474,495	99,717*	17.9M	—	Q2 FY26 10-QJun 30, 2026
Evolent Health	115,703	652,520	(9,312)*	113.1M	12.4 quarters	Q2 FY26 10-QJun 30, 2026
Genpact	517,387	1,343,438	72,443*	168.0M	—	Q2 FY26 10-QJun 30, 2026
Astrana Health	400,792	972,520	32,748*	55.7M	—	Q2 FY26 10-QJun 30, 2026
Booz Allen Hamilton Holding	334,000	2,778,000	294,000*	118.6M	—	Q2 FY27 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.